Biotech
PORTLAND, ME: Conference Call Scheduled for Wednesday, November 12, 2014 at 4:30PM EST ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/03/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that new data from an investigator-sponsored Phase 1/2 trial evaluating the comb ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/03/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), today reported financial results for the third quarter 2014. Revenue for the third quarter ende ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/03/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), today announced that Threshold's partner Merck KGaA, Darmstadt, Germany, through its bioph ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/31/14 -- BioDE Ventures Ltd. (the "Company" or "BioDE") is pleased to announce that it will enter into a loan agreement (the &q ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/31/14 -- BioHEP Technologies Ltd. (the "Company" or "BioHEP") is pleased to announce that it will enter into a loan agreement ( ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/31/14 -- Biosenta Inc. ("Biosenta" or the "Company") listed on the CSE (CSE: ZRO) announces that Matt Bassett has resigned from the Board ...
CHICAGO, IL: CHICAGO, IL -- (Marketwired) -- 10/31/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, today ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 10/31/14 -- (NASDAQ: ATOS) today announced that the U.S. District Court for the Western District of Washington has granted the defendants' motion to dismiss the ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 10/31/14 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, d ...
SAN FRANCISCO, CA and NORTHBROOK, IL: SAN FRANCISCO, CA and NORTHBROOK, IL -- (Marketwired) -- 10/30/14 -- Medivation Inc. (NASDAQ: MDVN) and Astellas today announced plans to initiate a global Phase 3 clinical trial that will evaluate t ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 10/30/14 -- Celmatix, a privately held personalized medicine company focused on maximizing lifelong fertility, today announced publication of a study evaluating the p ...
LONDON, ONTARIO: Another critical milestone achieved as low toxicity confirmed in pre-IND testing ...
CEDAR KNOLLS, NJ: Daily Use of Fortetropin Significantly Decreases Inflammatory Cytokine Levels; Company to Explore a Much Broader Range of Opportunities for Fortetropin as a Treatment Option for Inflammatory Condition ...
TUCSON, AZ: TUCSON, AZ -- (Marketwired) -- 10/30/14 -- HTG Molecular Diagnostics, Inc. (HTG), a provider of instruments and reagents for molecular profiling applications, today announced that it entered into an ...
EAST PROVIDENCE, RI and BERLIN, GERMANY: Dr. Sascha Gick and Dr. Steffen Heck of St. Vinzenz-Hospital Koln Awarded for Outstanding Scientific Achievements With IlluminOss' Photodynamic Bone Stabilization System ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/29/14 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the year ended July ...
VANCOUVER, BRITISH COLUMBIA: Autologous Cell Therapy, RCT-01, to Be Investigated for Treatment of Tendinopathies Refractory to Other Treatments ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 10/28/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:David Hung, M.D., president and chief executive offi ...
